| Basics |
Celldex Therapeutics, Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. The company is engaged in the development and commercialization of immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases.
|
| IPO Date: |
March 26, 1990 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.96B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.43 | 3.05%
|
| Avg Daily Range (30 D): |
$0.57 | 2.25%
|
| Avg Daily Range (90 D): |
$0.60 | 2.46%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.1M |
| Avg Daily Volume (30 D): |
.67M |
| Avg Daily Volume (90 D): |
.95M |
| Trade Size |
| Avg Trade Size (Sh.): |
158 |
| Avg Trade Size (Sh.) (30 D): |
53 |
| Avg Trade Size (Sh.) (90 D): |
74 |
| Institutional Trades |
| Total Inst.Trades: |
4,631 |
| Avg Inst. Trade: |
$2.1M |
| Avg Inst. Trade (30 D): |
$2.11M |
| Avg Inst. Trade (90 D): |
$2.13M |
| Avg Inst. Trade Volume: |
.05M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.85M |
| Avg Closing Trade (30 D): |
$2.71M |
| Avg Closing Trade (90 D): |
$2.68M |
| Avg Closing Volume: |
77.26K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-1.01
|
$-.85
|
$-.81
|
|
Diluted EPS
|
$-1.01
|
$-.85
|
$-.81
|
|
Revenue
|
$ M
|
$ .73M
|
$ .7M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -67.04M
|
$ -56.6M
|
$ -53.8M
|
|
Operating Income / Loss
|
$ -73.62M
|
$ -63.86M
|
$ -62.74M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 12.99M
|
$ 5.91M
|
$ -11.22M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Feb 11, 2019:
1:15
|
|
Mar 10, 2008:
1:12
|
|
Mar 07, 2008:
1:12
|
|
|
|
